Avila Therapeutics, a biopharma focused on viral infection, cancer and autoimmune diseases, appointed Katrine Bosley to CEO. Bosley was previously VP, strategic operations at Adnexus, acquired by Bristol-Myers Squibb in 2007. Prior to Adnexus, Bosley worked in various capacities – including business development, commercial operations and portfolio strategy – at Biogen Idec.
New York City-based Keryx Biopharmaceuticals announced the appointment of Ron Bentsur to CEO. Bensur was most recently CEO at XTL Biopharmaceuticals.